Use of Impella 5L for Acute Allograft Rejection Postcardiac Transplant

Abstract

The contribution of acute allograft rejection to posttransplant mortality has decreased over time primarily due to improvements in maintenance immunosuppression and in the diagnosis and treatment of rejection.[1]Nevertheless, acute heart allograft rejection remains an important clinical problem.[2] In the setting of an acute allograft rejection, mechanical circulatory support has been provided by a variety of devices, ranging from intra-aortic balloon pumps (IABP) to extracorporeal membrane oxygenators (ECMO), left ventricular assist devices (LVADs) and biventricular assist devices (BIVADs).[2] We present a 45-year-old patient with cardiogenic shock secondary to acute allograft rejection after orthotopic heart transplantation. Patient continued to have poor hemodynamics and low cardiac output despite being on high doses of inotropes and an aggressive immunosuppression. Hence, a decision was made to support the hemodynamics with an Impella LP 5.0 (Abiomed Inc, Danvers, MA) left ventricular assist device (LVAD).

Keywords

aortic valve & root - circulatory assist devices (IABP, LVAD, RVAD, BVAD, TAH) - transplantation - heart

• References

• 1 Hertz MI, Aurora P, Christie JD , et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J Heart Lung Transplant 2009; 28 (10) 989-992 See also www.ishlt.org/registries
• 2 Mihaljevic T, Jarrett CM, Gonzalez-Stawinski G , et al. Mechanical circulatory support after heart transplantation. Eur J Cardio Thorac Surg 2011; 41 (1) 200-206
• 3 Sauren LD, Accord RE, Hamzeh K , et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs 2007; 31 (11) 839-842
• 4 Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65 (2) 263-267
• 5 Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 2003; 41 (7) 1087-1095
• 6 Remmelink M, Sjauw KD, Henriques JP , et al. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007; 70 (4) 532-537
• 7 LaRocca GM, Shimbo D, Rodriguez CJ , et al. The Impella recover LP 5.0 LVAD: a bridge to coronary artery bypass grafting and cardiac transplantation. J Am Soc Echocardiogr 2006; 19 (4) 468.e5-468.e7
• 8 Rossiter-Thornton M, Arun V, Forrest AP, Bayfield MS, Wilson MK. Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery. Heart Lung Circ 2008; 17 (3) 243-245
• 9 Hunt SA. Complications of heart transplantation. J Heart Transplant 1983; 3: 70-74
• 10 Petrofski JA, Patel VS, Russell SD. MJilano CA. BVS5000 support after cardiac transplantation. J Thorac Cardiovasc Surg 2003; 126 (2) 442-447